Cyclacel pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Cyclacel pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 2.348 million compared to usd 2.455 million a year ago. net loss was usd 1.901 million compared to usd 2.068 million a year ago. basic loss per share was usd 0.11 compared to usd 0.18 a year ago. for the nine months, operating loss was usd 6.888 million compared to usd 7.083 million a year ago. net loss was usd 5.525 million compared to usd 5.270 million a year ago. basic loss per share was usd 0.35 compared to usd 0.45 a year ago.
CYCC Ratings Summary
CYCC Quant Ranking